These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 9934546)

  • 1. Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
    Sader HS; Jones RN; Gales AC; Winokur P; Kugler KC; Pfaller MA; Doern GV
    Diagn Microbiol Infect Dis; 1998 Dec; 32(4):289-301. PubMed ID: 9934546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998).
    Lewis MT; Gales AC; Sader HS; Pfaller MA; Jones RN
    Diagn Microbiol Infect Dis; 2000 May; 37(1):63-74. PubMed ID: 10794943
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia in Latin America: frequency of occurrence and antimicrobial susceptibility profile: results from the SENTRY Antimicrobial Surveillance Program (1997-2000).
    Gales AC; Sader H HS; Jones RN
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):301-11. PubMed ID: 12493178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial Pathogens Isolated from Patients with Bloodstream Infections in Latin America, 1997: Frequency of Occurrence and Antimicrobial Susceptibility Patterns from the SENTRY Antimicrobial Surveillance Program.
    Sader HS; Pfaller MA; Jones RN; Doern GV; Gales AC; Winokur PL; Kugler KC
    Braz J Infect Dis; 1999 Jun; 3(3):97-110. PubMed ID: 11097713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial activity of 41 antimicrobials tested against over 2773 bacterial isolates from hospitalized patients with pneumonia: I--results from the SENTRY Antimicrobial Surveillance Program (North America, 1998).
    Mathai D; Lewis MT; Kugler KC; Pfaller MA; Jones RN;
    Diagn Microbiol Infect Dis; 2001 Feb; 39(2):105-16. PubMed ID: 11248523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathogen of occurrence and susceptibility patterns associated with pneumonia in hospitalized patients in North America: results of the SENTRY Antimicrobial Surveillance Study (2000).
    Hoban DJ; Biedenbach DJ; Mutnick AH; Jones RN
    Diagn Microbiol Infect Dis; 2003 Apr; 45(4):279-85. PubMed ID: 12730000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
    Jones RN; Sader HS; Fritsche TR; Pottumarthy S
    Diagn Microbiol Infect Dis; 2007 Jan; 57(1):109-16. PubMed ID: 16930923
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
    Sader HS; Jones RN; Silva JB;
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):281-8. PubMed ID: 12493176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacterial pathogens isolated from patients with skin and soft tissue infections: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997). SENTRY Study Group (North America).
    Doern GV; Jones RN; Pfaller MA; Kugler KC; Beach ML
    Diagn Microbiol Infect Dis; 1999 May; 34(1):65-72. PubMed ID: 10342110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group.
    Gales AC; Jones RN; Pfaller MA; Gordon KA; Sader HS
    Int J Infect Dis; 2000; 4(2):75-84. PubMed ID: 10737843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial Activity of High-Proportion Cefepime-Tazobactam (WCK 4282) against a Large Number of Gram-Negative Isolates Collected Worldwide in 2014.
    Sader HS; Castanheira M; Mendes RE; Flamm RK; Jones RN
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28137811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
    Sader HS; Fritsche TR; Jones RN
    Diagn Microbiol Infect Dis; 2005 Jul; 52(3):265-73. PubMed ID: 16105569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of pathogens causing urinary tract infections in hospitals in North America: results from the SENTRY Antimicrobial Surveillance Program, 1997.
    Jones RN; Kugler KC; Pfaller MA; Winokur PL
    Diagn Microbiol Infect Dis; 1999 Sep; 35(1):55-63. PubMed ID: 10529882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
    Sader HS; Jones RN; Andrade-Baiocchi S; Biedenbach DJ;
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):273-80. PubMed ID: 12493175
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial susceptibility of Gram-negative organisms isolated from patients hospitalized in intensive care units in United States and European hospitals (2009-2011).
    Sader HS; Farrell DJ; Flamm RK; Jones RN
    Diagn Microbiol Infect Dis; 2014 Apr; 78(4):443-8. PubMed ID: 24492025
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathogen occurrence and antimicrobial resistance trends among urinary tract infection isolates in the Asia-Western Pacific Region: report from the SENTRY Antimicrobial Surveillance Program, 1998-1999.
    Turnidge J; Bell J; Biedenbach DJ; Jones RN
    Int J Antimicrob Agents; 2002 Jul; 20(1):10-7. PubMed ID: 12127706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
    Fritsche TR; Sader HS; Jones RN
    Diagn Microbiol Infect Dis; 2008 May; 61(1):86-95. PubMed ID: 18385000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the in vitro activity of six broad-spectrum beta-lactam antimicrobial agents tested against over 2,000 clinical isolates from 22 medical centers in Japan. Japan Antimicrobial Resistance Study Group.
    Yamaguchi K; Mathai D; Biedenbach DJ; Lewis MT; Gales AC; Jones RN
    Diagn Microbiol Infect Dis; 1999 Jun; 34(2):123-34. PubMed ID: 10354863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial Activity of Ceftazidime-Avibactam against Gram-Negative Bacteria Isolated from Patients Hospitalized with Pneumonia in U.S. Medical Centers, 2011 to 2015.
    Sader HS; Castanheira M; Flamm RK
    Antimicrob Agents Chemother; 2017 Apr; 61(4):. PubMed ID: 28069649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antimicrobial resistance among Gram-negative bacilli isolated from Latin America: results from SENTRY Antimicrobial Surveillance Program (Latin America, 2008-2010).
    Gales AC; Castanheira M; Jones RN; Sader HS
    Diagn Microbiol Infect Dis; 2012 Aug; 73(4):354-60. PubMed ID: 22656912
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.